DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
Issue S 1 ·
Volume 59 ·
September 1991
DOI: 10.1055/s-002-8040
1
2
Ackenheil, M.:
The Biochemical Action Profile of Zotepine Compared with that of Other Neuroleptics
10
Fleischhacker, W. W.;
Barnas, C.;
Stuppäck, C. H.;
Sperner-Unterweger, B.;
Miller, C.;
Hinterhuber, H.:
Zotepine vs Haloperidol in Paranoid Schizophrenia: A Double-Blind Study
14
Klieser, E.;
Lehmann, E.;
Tegeler, J.:
Double-Blind Comparison of 3 × 75 mg Zotepine and 3 × 4 mg Haloperidol in Acute Schizophrenics
18
Dieterle, Doris M.;
Müller-Spahn, F.;
Ackenheil, M.:
Efficacy and Tolerance of Zotepine in a Double-Blind Comparison with Perazin in Schizophrenics
23
Wetzel, H.;
Bardeleben, U. v;
Holsboer, F.;
Benkert, O.:
Zotepine versus Perazine in Paranoid Schizophrenia: a Double-blind Controlled Trial of Antipsychotic Efficacy
30
Müller-Spahn, F.;
Dieterle, D.;
Ackenheil, M.:
Clinical Efficacy of Zotepine in the Treatment of Schizophrenic Negative Symptoms Results of an Open and a Double-Blind Controlled Study
36
Barnas, C.;
Stuppäck, C. H.;
Miller, C.;
Haring, C.;
Sperner-Unterweger, B.;
Fleischhacker, W. W.:
Zotepine: Treatment of Schizophrenic Patients Presenting with Predominantly Negative Symptoms - A Double-Blind Study vs Haloperidol
41
Harada, T.;
Otsuki, S.;
Fujiwara, Y.:
Efficacy of Zotepine in Therapy-Resistant Psychoses
45
Saletu, B.;
Grünberger, J.;
Anderer, P.;
Chwatal, K.:
Relationship between blood levels and pharmacodynamics measured by quantitative EEG and psychometry after zotepine
56
